vs
Penumbra Inc(PEN)与泰利福(TFX)财务数据对比。点击上方公司名可切换其他公司
泰利福净利率更高(177.8% vs 12.3%,领先165.5%)。Penumbra Inc同比增速更快(22.1% vs -150.5%)。Penumbra Inc自由现金流更多($68.0M vs $-92.9M)。过去两年泰利福的营收复合增速更高(NaN% vs NaN%)
Penumbra Inc是2004年由Arani Bose与Adam Elsesser联合创立的美国医疗器械企业,总部位于加利福尼亚州阿拉米达,核心业务为研发、生产中风、动脉瘤等血管疾病介入治疗所用的专业医疗设备,产品已在全球多个国家的临床诊疗场景中投入使用。
泰利福(Teleflex)总部位于美国宾夕法尼亚州韦恩,是专业医疗设备供应商,产品广泛应用于重症监护、外科手术等各类诊疗场景。公司年营收达24亿美元,在全球40个国家开展业务,员工总数超15000人。经过数年的收并购与业务剥离,公司于2011年完成业务调整,全面聚焦医疗设备制造领域。
PEN vs TFX — 直观对比
营收规模更大
PEN
是对方的-1.0倍
$-401.9M
营收增速更快
PEN
高出172.7%
-150.5%
净利率更高
TFX
高出165.5%
12.3%
自由现金流更多
PEN
多$161.0M
$-92.9M
两年增速更快
TFX
近两年复合增速
17.6%
损益表 — Q4 2025 vs Q4 2025
| 指标 | ||
|---|---|---|
| 营收 | $385.4M | $-401.9M |
| 净利润 | $47.3M | $-714.3M |
| 毛利率 | 68.0% | — |
| 营业利润率 | 15.4% | — |
| 净利率 | 12.3% | 177.8% |
| 营收同比 | 22.1% | -150.5% |
| 净利润同比 | 40.6% | -422.7% |
| 每股收益(稀释后) | $1.20 | $-15.85 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
PEN
TFX
| Q4 25 | $385.4M | $-401.9M | ||
| Q3 25 | $354.7M | $913.0M | ||
| Q2 25 | $339.5M | $780.9M | ||
| Q1 25 | $324.1M | $700.7M | ||
| Q4 24 | $315.5M | $795.4M | ||
| Q3 24 | $301.0M | $764.4M | ||
| Q2 24 | $299.4M | $749.7M | ||
| Q1 24 | $278.7M | $737.8M |
净利润
PEN
TFX
| Q4 25 | $47.3M | $-714.3M | ||
| Q3 25 | $45.9M | $-408.9M | ||
| Q2 25 | $45.3M | $122.6M | ||
| Q1 25 | $39.2M | $95.0M | ||
| Q4 24 | $33.7M | $-136.7M | ||
| Q3 24 | $29.5M | $111.0M | ||
| Q2 24 | $-60.2M | $80.0M | ||
| Q1 24 | $11.0M | $15.3M |
毛利率
PEN
TFX
| Q4 25 | 68.0% | — | ||
| Q3 25 | 67.8% | 49.5% | ||
| Q2 25 | 66.0% | 55.2% | ||
| Q1 25 | 66.6% | 55.6% | ||
| Q4 24 | 66.8% | 55.3% | ||
| Q3 24 | 66.5% | 56.3% | ||
| Q2 24 | 54.4% | 55.6% | ||
| Q1 24 | 65.0% | 56.4% |
营业利润率
PEN
TFX
| Q4 25 | 15.4% | — | ||
| Q3 25 | 13.8% | -44.8% | ||
| Q2 25 | 12.0% | 19.9% | ||
| Q1 25 | 12.4% | 17.9% | ||
| Q4 24 | 13.6% | -13.9% | ||
| Q3 24 | 11.7% | 19.5% | ||
| Q2 24 | -27.0% | 15.6% | ||
| Q1 24 | 4.3% | -0.6% |
净利率
PEN
TFX
| Q4 25 | 12.3% | 177.8% | ||
| Q3 25 | 12.9% | -44.8% | ||
| Q2 25 | 13.3% | 15.7% | ||
| Q1 25 | 12.1% | 13.6% | ||
| Q4 24 | 10.7% | -17.2% | ||
| Q3 24 | 9.8% | 14.5% | ||
| Q2 24 | -20.1% | 10.7% | ||
| Q1 24 | 3.9% | 2.1% |
每股收益(稀释后)
PEN
TFX
| Q4 25 | $1.20 | $-15.85 | ||
| Q3 25 | $1.17 | $-9.24 | ||
| Q2 25 | $1.15 | $2.77 | ||
| Q1 25 | $1.00 | $2.07 | ||
| Q4 24 | $0.88 | $-2.89 | ||
| Q3 24 | $0.75 | $2.36 | ||
| Q2 24 | $-1.55 | $1.69 | ||
| Q1 24 | $0.28 | $0.32 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $186.9M | $378.6M |
| 总债务越低越好 | — | $2.6B |
| 股东权益账面价值 | $1.4B | $3.1B |
| 总资产 | $1.8B | $6.9B |
| 负债/权益比越低杠杆越低 | — | 0.85× |
8季度趋势,按日历期对齐
现金及短期投资
PEN
TFX
| Q4 25 | $186.9M | $378.6M | ||
| Q3 25 | $321.0M | $354.0M | ||
| Q2 25 | $421.8M | $253.7M | ||
| Q1 25 | $376.1M | $284.1M | ||
| Q4 24 | $324.4M | $290.2M | ||
| Q3 24 | $280.5M | $243.2M | ||
| Q2 24 | $288.3M | $238.6M | ||
| Q1 24 | $223.1M | $237.4M |
总债务
PEN
TFX
| Q4 25 | — | $2.6B | ||
| Q3 25 | — | $2.7B | ||
| Q2 25 | — | $1.9B | ||
| Q1 25 | — | $1.9B | ||
| Q4 24 | — | $1.7B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益
PEN
TFX
| Q4 25 | $1.4B | $3.1B | ||
| Q3 25 | $1.4B | $3.8B | ||
| Q2 25 | $1.3B | $4.2B | ||
| Q1 25 | $1.2B | $4.1B | ||
| Q4 24 | $1.2B | $4.3B | ||
| Q3 24 | $1.1B | $4.5B | ||
| Q2 24 | $1.2B | $4.6B | ||
| Q1 24 | $1.2B | $4.5B |
总资产
PEN
TFX
| Q4 25 | $1.8B | $6.9B | ||
| Q3 25 | $1.7B | $7.9B | ||
| Q2 25 | $1.7B | $7.4B | ||
| Q1 25 | $1.6B | $7.2B | ||
| Q4 24 | $1.5B | $7.1B | ||
| Q3 24 | $1.5B | $7.5B | ||
| Q2 24 | $1.5B | $7.4B | ||
| Q1 24 | $1.6B | $7.5B |
负债/权益比
PEN
TFX
| Q4 25 | — | 0.85× | ||
| Q3 25 | — | 0.70× | ||
| Q2 25 | — | 0.45× | ||
| Q1 25 | — | 0.47× | ||
| Q4 24 | — | 0.39× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $86.5M | $-92.3M |
| 自由现金流经营现金流 - 资本支出 | $68.0M | $-92.9M |
| 自由现金流率自由现金流/营收 | 17.7% | 23.1% |
| 资本支出强度资本支出/营收 | 4.8% | -0.2% |
| 现金转化率经营现金流/净利润 | 1.83× | — |
| 过去12个月自由现金流最近4个季度 | $174.9M | $1.4M |
8季度趋势,按日历期对齐
经营现金流
PEN
TFX
| Q4 25 | $86.5M | $-92.3M | ||
| Q3 25 | $58.3M | $107.8M | ||
| Q2 25 | $44.9M | $7.8M | ||
| Q1 25 | $49.0M | $73.3M | ||
| Q4 24 | $51.1M | $202.6M | ||
| Q3 24 | $56.5M | $231.1M | ||
| Q2 24 | $22.6M | $91.7M | ||
| Q1 24 | $38.3M | $112.8M |
自由现金流
PEN
TFX
| Q4 25 | $68.0M | $-92.9M | ||
| Q3 25 | $42.0M | $77.8M | ||
| Q2 25 | $29.4M | $-26.8M | ||
| Q1 25 | $35.5M | $43.3M | ||
| Q4 24 | $45.7M | $170.6M | ||
| Q3 24 | $51.0M | $209.9M | ||
| Q2 24 | $18.1M | $56.9M | ||
| Q1 24 | $32.5M | $74.4M |
自由现金流率
PEN
TFX
| Q4 25 | 17.7% | 23.1% | ||
| Q3 25 | 11.8% | 8.5% | ||
| Q2 25 | 8.7% | -3.4% | ||
| Q1 25 | 11.0% | 6.2% | ||
| Q4 24 | 14.5% | 21.4% | ||
| Q3 24 | 16.9% | 27.5% | ||
| Q2 24 | 6.0% | 7.6% | ||
| Q1 24 | 11.7% | 10.1% |
资本支出强度
PEN
TFX
| Q4 25 | 4.8% | -0.2% | ||
| Q3 25 | 4.6% | 3.3% | ||
| Q2 25 | 4.6% | 4.4% | ||
| Q1 25 | 4.2% | 4.3% | ||
| Q4 24 | 1.7% | 4.0% | ||
| Q3 24 | 1.8% | 2.8% | ||
| Q2 24 | 1.5% | 4.6% | ||
| Q1 24 | 2.1% | 5.2% |
现金转化率
PEN
TFX
| Q4 25 | 1.83× | — | ||
| Q3 25 | 1.27× | — | ||
| Q2 25 | 0.99× | 0.06× | ||
| Q1 25 | 1.25× | 0.77× | ||
| Q4 24 | 1.52× | — | ||
| Q3 24 | 1.91× | 2.08× | ||
| Q2 24 | — | 1.15× | ||
| Q1 24 | 3.48× | 7.38× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图